Skip to content

Ibuprofen With or Without Dexamethasone for Acute Radicular Low Back Pain.

Ibuprofen With or Without Dexamethasone for Acute Radicular Low Back Pain.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05721027
Enrollment
132
Registered
2023-02-09
Start date
2023-07-05
Completion date
2027-10-01
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back Pain With Radiation, Low Back Pain, Radiculopathy, Lumbosacral Region

Keywords

ibuprofen, dexamethasone, radiculopathy, low back pain, back pain with radiation

Brief summary

This will be a placebo controlled, randomized, double-blind, comparative effectiveness study, in which we patients are enrolled during an emergency department (ED) visit for acute radicular low back pain (LBP) and followed by telephone two and seven days later. Patients will be randomized to receive an oral dose of dexamethasone for 2 consecutive days or placebo during an ED visit for acute radicular LBP. Every patient will receive a 7 day supply of ibuprofen and a low back pain education session.

Interventions

BEHAVIORALEducational Intervention

Research personnel will provide each patient with a 15-minute educational intervention. This will be based on National Institute of Arthritis and Musculoskeletal and Skin Diseases Handout on Health: Back Pain information

DRUGIbuprofen 400 mg

Ibuprofen 400 mg PO every 8 hours as needed for 7 days

DRUGDexamethasone Oral

Dexamethasone 16 mg PO during ED visit and next day

Sponsors

Montefiore Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Present to ED primarily for management of acute radicular LBP, defined as pain or paresthesia originating from the lower back and radiating to the buttock and or leg in a radicular pattern. Some patients may not have prominent LBP but a radicular symptom--we will include these patients as well. * Patient is to be discharged home. * Age 18-70 Enrollment will be limited to adults \<70 years because of the increased risk of adverse medication effects in older adults. * Pain duration \<2 week * Prior to the acute attack of radicular LBP, back pain cannot occur more frequently than half of the days in the last 3 months. Patients with more frequent back pain/sciatica are at increased risk of poor pain and functional outcomes.10 * Non-traumatic cause of pain: no substantial and direct trauma to the back within the previous month * Functionally impairing radicular LBP: A baseline score of \> 5 on the Roland-Morris Disability Questionnaire

Exclusion criteria

* Not available for follow-up * Pregnant * Chronic pain syndrome defined as use of any analgesic medication on a daily or near-daily basis * Allergic to or intolerant of investigational medications * Chronic steroid use * Contra-indications to investigational medications: 1) known peptic ulcer disease, chronic dyspepsia, or history of gastrointestinal bleed 2) Severe heart failure (NYHA 2 or worse) 3) Chronic kidney disease (GFR \<60ml/min) 4) Current use of anti-coagulants 5) cirrhosis (Child Pugh A or worse) or hepatitis (transaminases 2x the upper limit of normal)

Design outcomes

Primary

MeasureTime frameDescription
Change in Roland Morris Disability Questionnaire (RMDQ) score2 days (48 hours)The change in RMDQ will be evaluated using the 24-item Roland Morris Low Back Pain Disability Questionnaire. The RMDQ is a 24-item patient-reported outcome measure that inquires about pain-related disability resulting from LBP. Items are scored 0 if left blank or 1 if endorsed, for a total RMDQ score ranging from 0 to 24. Higher scores represent higher levels of pain-related disability. The change will be calculated as a difference between the baseline ED visit and the two day follow-up visit (Roland-Morris baseline - Roland-Morris day 2)

Secondary

MeasureTime frameDescription
Worst Radicular LBP2 days and 7 days after ED dischargeWorst Radicular LBP pain incurred over the previous 24 hours will be assessed at 2 days and 7 days after ED discharge using a four point ordinal scale: Severe, Moderate, Mild, or None
Frequency of Radicular LBP2 days and 7 days after ED dischargeFrequency of Radicular LBP is evaluated at 2 days and 7 days after ED discharge based on a five point Likert scale: Not at all, Rarely, Sometimes, Usually, and Always
Analgesic or LBP medication within the previous 24 hours2 days and 7 days after ED dischargeAdministration of any analgesic or LBP medication (Yes or No) within the previous 24 hours will be assessed at 2 days and 7 days after ED discharge
Absolute Roland Morris Disability Questionnaire (RMDQ) score2 days and 7 days after ED dischargeThe Absolute RMDQ score will be tabulated at 2 days and 7 days after ED discharge. The RMDQ is a 24-item patient-reported outcome measure that inquires about pain-related disability resulting from LBP. Items are scored 0 if left blank or 1 if endorsed, for a total RMDQ score ranging from 0 to 24. Higher scores represent higher levels of pain-related disability
Return to all usual activities2 days and 7 days after ED dischargeThe patient will be evaluated for the ability to return to all usual activities at 2 days and 7 days after ED discharge based on a binary (Yes/No) response
Number of visits to any healthcare provider2 days and 7 days after ED dischargeThe number of aggregate visits to any healthcare provider will be tabulated at 2 days and 7 days after ED discharge
Satisfaction with Treatment2 days and 7 days after ED dischargeSatisfaction with treatment will be evaluated based on a binary (Yes/No) response at 2 days and 7 days after ED discharge

Countries

United States

Contacts

CONTACTEddie Irizarry, MD
eddiriza@montefiore.org718-920-6626
PRINCIPAL_INVESTIGATOREddie Irizarry, MD

Montefiore Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026